Clinical Trials List
2017-07-15 - 2022-06-30
Phase III
Terminated2
ICD-10C67
Malignant neoplasm of bladder
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- Shang-Yin Wu Division of General Internal Medicine
- Ya-Ting Hsu Division of General Internal Medicine
- Jui-Hung Tsai Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
- Wu-Chou Su Division of General Internal Medicine
- 劉奕廷 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
Taiwan National PI
Co-Principal Investigator
- Po-Jung Su Division of Hematology & Oncology
- 劉忠一 Division of Hematology & Oncology
- See-Tong Pang Division of Hematology & Oncology
- Yung-Chia Kao Division of Hematology & Oncology
- 張英勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
8 participants
-
Global
1000 participants
